In:
Cancer, Wiley, Vol. 100, No. 9 ( 2004-05), p. 1814-1822
Abstract:
Proteomic changes were examined in response to chemotherapy in patients with Stage I–III breast carcinoma, and plasma profiles from patients with breast carcinoma were compared with the profiles from healthy women to identify breast carcinoma‐associated protein markers. Five mass peaks were identified that were absent in healthy women and one unique chemotherapy‐induced peak. These peaks may represent markers that have the potential to detect and monitor micrometastatic disease after surgery.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
Language:
English
Publisher:
Wiley
Publication Date:
2004
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
1429-1